Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 134-146, April 2007

Chimerism in the Immunohematology Laboratory in the Molecular Biology Era

SUNY Downstate Medical Center, Brooklyn, NY

Laboratory of Immunohematology, New York Blood Center, New York, NY

Blood Bank and Transfusion Medicine Department, Hadassah Medical Center, Hebrew University, Jerusalem, Israel

Dual or multiple cell populations, induced by chimeras, have been the subject of many studies. This long-standing fascination with chimeras has revealed a good deal of knowledge about human inheritance. Although historically most chimeras were caused by natural events, certain current medical intervention therapies are increasing the number of situations that can lead to a mixed cell population, that is, the chimeric condition, in humans. Medical therapies such as transfusion, stem cell transplantation, kidney transplantation, and artificial insemination induce temporary and sometimes permanent chimeras. Such natural or therapeutically induced presentations of chimerism can present challenging issues to the clinical immunohematology laboratory with regard to interpretation of results and subsequent patient management. The purpose of this review was to highlight some of these chimeric states and hypothesize how testing DNA from various tissues can cause apparent discrepancies between phenotype and genotype results.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by NIH SCOR grant HL54459 (MER).

PII: S0887-7963(06)00095-2

doi:10.1016/j.tmrv.2006.11.002

Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 134-146, April 2007